4.6 Article

A DNA synthesis inhibitor is protective against proteotoxic stressors via modulation of fertility pathways in Caenorhabditis elegans

期刊

AGING-US
卷 5, 期 10, 页码 759-769

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/aging.100605

关键词

FUdR; germline; protein misfolding; reproduction

资金

  1. Larry L. Hillblom Foundation
  2. NIH [UL1024917, AG000266, 1F32ES022370-01A1]
  3. Interdisciplinary Research Consortium on Geroscience [1R01AG029631-01A1, AG042053]

向作者/读者索取更多资源

Loss of germline precursor cells in C. elegans has previously been shown to improve protein homeostasis and extend lifespan, possibly due to reallocation of resources to somatic cells. In contrast, mutants that are sterile simply due to loss of sperm or oocyte production have a normal lifespan, often leading to the conclusion that loss of reproduction per se may have minor effects on C. elegans. We have found that inhibiting reproduction in C. elegans via the DNA synthesis inhibitor 5-fluoro-2-deoxyuridine (FUdR) improves protein homeostasis, stress resistance, and healthspan in wild-type animals. We find that FUdR is dependent on oogenesis and oocytic maturation. The effects of FUdR are dependent on FEM pathways, which regulate initiation of spermatogenesis. Loss of FEM expression leads to feminized animals that maintain arrested oocytes and are refractory to the effects of FUdR. FUdR-dependence is restored by spermatogenic signals, which trigger oocytic maturation and ovulation. Further, loss of FEM-3, a novel protein required for spermatogenesis, is sufficient to improve aspects of proteostasis. These effects are independent of previously described germline signals, including the DAF-16/FOXO, DAF-12/VDR, and HSF-1 pathways. These findings suggest that genetic or chemical inhibition of oocyte production can improve protein homeostasis in C. elegans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling

F. Kruiswijk, S. C. Hasenfuss, R. Sivapatham, M. P. Baar, D. Putavet, K. A. T. Naipal, N. J. F. van den Broek, W. Kruit, P. J. van der Spek, D. C. van Gent, A. B. Brenkman, J. Campisi, B. M. T. Burgering, J. H. J. Hoeijmakers, P. L. J. de Keizer

ONCOGENE (2016)

Article Pharmacology & Pharmacy

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Diseases

Edilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J. Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pahler, Julie K. Andersen, Rene Wyler, Andrea M. Cesura

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Article Cell Biology

Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease

Dmitri Leonoudakis, Anand Rane, Suzanne Angeli, Gordon J. Lithgow, Julie K. Andersen, Shankar J. Chinta

MEDIATORS OF INFLAMMATION (2017)

Article Neurosciences

A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo

Banibrata Das, Subramanian Rajagopalan, Gnanada S. Joshi, Liping Xu, Dan Luo, Julie K. Andersen, Sokol V. Todi, Aloke K. Dutta

NEUROPHARMACOLOGY (2017)

Article Multidisciplinary Sciences

Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects

Mark Lucanic, W. Todd Plummer, Esteban Chen, Jailynn Harke, Anna C. Foulger, Brian Onken, Anna L. Coleman-Hulbert, Kathleen J. Dumas, Suzhen Guo, Erik Johnson, Dipa Bhaumik, Jian Xue, Anna B. Crist, Michael P. Presley, Girish Harinath, Christine A. Sedore, Manish Chamoli, Shaunak Kamat, Michelle K. Chen, Suzanne Angeli, Christina Chang, John H. Willis, Daniel Edgar, Mary Anne Royal, Elizabeth A. Chao, Shobhna Patel, Theo Garrett, Carolina Ibanez-Ventoso, June Hope, Jason L. Kish, Max Guo, Gordon J. Lithgow, Monica Driscoll, Patrick C. Phillips

NATURE COMMUNICATIONS (2017)

Review Clinical Neurology

An inducible MAO-B mouse model of Parkinson's disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics

Manish Chamoli, Shankar J. Chinta, Julie K. Andersen

JOURNAL OF NEURAL TRANSMISSION (2018)

Article Neurosciences

Hsp90 Co-chaperone p23 contributes to dopaminergic mitochondrial stress via stabilization of PHD2: Implications for Parkinson's disease

Anand Rane, Subramanian Rajagopalan, Manuj Ahuja, Bobby Thomas, Shankar J. Chinta, Julie K. Andersen

NEUROTOXICOLOGY (2018)

Article Toxicology

Screening Method for Identifying Toxicants Capable of Inducing Astrocyte Senescence

Georgia Woods, Julie K. Andersen

TOXICOLOGICAL SCIENCES (2018)

Article Cell Biology

Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease

Shankar J. Chinta, Georgia Woods, Marco Demaria, Anand Rane, Ying Zou, Amanda McQuade, Subramanian Rajagopalan, Chandani Limbad, David T. Madden, Judith Campisi, Julie K. Andersen

CELL REPORTS (2018)

Article Multidisciplinary Sciences

Quantification of Insoluble Protein Aggregation in Caenorhabditis elegans during Aging with a Novel Data-Independent Acquisition Workflow

Xueshu Xie, Manish Chamoli, Dipa Bhaumik, Renuka Sivapatham, Suzanne Angeli, Julie K. Andersen, Gordon J. Lithgow, Birgit Schilling

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2020)

Article Biology

The mitochondrial permeability transition pore activates the mitochondrial unfolded protein response and promotes aging

Suzanne Angeli, Anna Foulger, Manish Chamoli, Tanuja Harshani Peiris, Akos Gerencser, Azar Asadi Shahmirzadi, Julie Andersen, Gordon Lithgow

Summary: Mitochondrial activity plays a crucial role in determining aging rate and the onset of chronic diseases. Research suggests that the destabilization of OSCP in the inner mitochondrial membrane may promote aging by initiating the mPTP. Inhibition of mPTP can suppress UPRmt and restore normal lifespan, indicating a potential protective role of UPRmt inhibition in aging and age-related diseases.
Article Cell Biology

Chemically induced reprogramming to reverse cellular aging

Jae-Hyun Yang, Christopher A. Petty, Thomas Dixon-McDougall, Maria Vina Lopez, Alexander Tyshkovskiy, Sun Maybury-Lewis, Xiao Tian, Nabilah Ibrahim, Zhili Chen, Patrick T. Griffin, Matthew Arnold, Jien Li, Oswaldo A. Martinez, Alexander Behn, Ryan Rogers-Hammond, Suzanne Angeli, Vadim N. Gladyshev, David A. Sinclair

Summary: A hallmark of eukaryotic aging is a loss of epigenetic information, a process that can be reversed. By ectopically inducing the Yamanaka factors OCT4, SOX2, and KLF4 (OSK) in mammals, we can restore youthful characteristics without changing cellular identity. Through high-throughput cell-based assays, we have identified six chemical cocktails that can reverse cellular aging and rejuvenate human cells without altering the genome.

AGING-US (2023)

Article Cell & Tissue Engineering

mTORC1 Activation during Repeated Regeneration Impairs Somatic Stem Cell Maintenance

Samantha Haller, Subir Kapuria, Rebeccah R. Riley, Monique N. O'Leary, Katherine H. Schreiber, Julie K. Andersen, Simon Melov, Jianwen Que, Thomas A. Rando, Jason Rock, Brian K. Kennedy, Joseph T. Rodgers, Heinrich Jasper

CELL STEM CELL (2017)

Meeting Abstract Cell & Tissue Engineering

ASSAY DEVELOPMENT AND CELL CHARACTERIZATION CHALLENGES OF HUMAN INDUCED PLURIPOTENT STEM CELLS FOR CELL THERAPY APPLICATIONS

B. Ahmadian Baghbaderani, A. Syama, R. Sivapatham, Y. Pei, O. Mukherjee, X. Tian, H. Tran, L. Menendez, T. Fellner, X. Zeng, M. Rao

CYTOTHERAPY (2017)

暂无数据